Why this article
"Can I take a mushroom supplement during chemotherapy" is one of the most common — and most dangerous — questions to self-answer. Oncology is where "natural" meets drugs with a narrow therapeutic window, and the internet answers either "everything is fine" (supplement sellers) or "nothing is allowed" (people who do not read the data). The honest answer is this is a question for your physician — but it has to be a specific question. Below is how to ask it.
What is on the data shelf
Mushroom oncology is the only area where there is more than "preclinical and hope" — there is human work:
- PSK (krestin) from trametes — an official adjuvant drug in Japan for several cancers; meta-analyses exist for survival in gastric and colorectal cancer. We cover it in the PSK meta-analysis card.
- Phase I tolerability trials: trametes up to 9 g/day in women after breast-cancer treatment; Agaricus blazei in 78 patients in remission.
- Maitake D-fraction — the Deng 2009 study in post-breast-cancer patients; the card matters for its honest finding: the immune-marker response was non-monotonic — activation at some doses, suppression at others. That is the core "don't mess with it yourself" argument: a polysaccharide is not a dimmer, it is a curve with an inflection point.
Five questions for your oncologist
Phrased so the physician can answer concretely, not "you know, supplements are useless".
- "Does this supplement interact with my regimen?" — name the specific product and dose. The practical point: reishi raises plasma antioxidant capacity (human data), and that could theoretically interfere with regimens working through oxidative stress — platinum, alkylators. It is a hypothesis, not proven harm, but worth raising before the course.
- "I'm on anticoagulants / glucose-lowering drugs — is this compatible?" Documented: maitake + warfarin → INR elevation (case report); reishi and bleeding risk per the MSKCC monograph. If you are on warfarin, insulin or oral hypoglycemics — a supplement changes the background.
- "Will the supplement affect my lab tests?" — a rare but real case: reishi spore powder raises the tumour marker CA72-4 — the result can look like progression and trigger unnecessary workups. Your physician must know about the intake before interpreting markers.
- "Are there adjuvant data for my cancer type?" An honest frame: human data exist for PSK (Japan, specific localizations), and Phase I data for some species. For most supplements the answer will be "no data" — and that is also an answer: the bet is tolerability, not treatment.
- "Can I start after the course rather than during?" — in many situations it is wiser to delay the supplement until therapy ends: otherwise it is impossible to tell where the markers shifted from, and an interaction lands mid-cycle.
Three things supplements do not replace
- A supplement is not treatment. All positive human data on fungi are adjuvant (on top of standard therapy) or tolerability data. No study has shown chemotherapy replacement.
- A supplement is not prevention. Preventive claims ("protects against cancer") are marketing; no human interventional study has proven that.
- A supplement is not "just in case". Given lab traps (CA72-4) and interactions, "why not" carries a real price.
Where to look for verified information yourself
- MSKCC About Herbs — a free database of supplement monographs written by the cancer centre's pharmacist-botanist; each mushroom has a "Herb-Drug Interactions" section.
- NCI PDQ (US National Cancer Institute) — integrative-oncology sections with physician-level evidence ratings.
- Our research cards — filter by the "oncology" and "safety" categories.